Fresenius Financial Statements From 2010 to 2024
| FME Stock | EUR 41.35 0.01 0.02% |
Check Fresenius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fresenius Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Fresenius financial statements analysis is a perfect complement when working with Fresenius Medical Valuation or Volatility modules.
Fresenius |
Fresenius Medical Care Company Profit Margin Analysis
Fresenius Medical's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Fresenius Medical Profit Margin | 0.03 % |
Most of Fresenius Medical's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresenius Medical Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Fresenius Medical Care has a Profit Margin of 0.0347%. This is 100.31% lower than that of the Healthcare sector and 100.68% lower than that of the Medical Care industry. The profit margin for all Germany stocks is 102.73% lower than that of the firm.
Fresenius Medical Care Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Fresenius Medical's current stock value. Our valuation model uses many indicators to compare Fresenius Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fresenius Medical competition to find correlations between indicators driving Fresenius Medical's intrinsic value. More Info.Fresenius Medical Care is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.46 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Fresenius Medical Care is roughly 2.19 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Fresenius Medical's earnings, one of the primary drivers of an investment's value.About Fresenius Medical Financial Statements
Fresenius Medical stakeholders use historical fundamental indicators, such as Fresenius Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Fresenius Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Fresenius Medical's assets and liabilities are reflected in the revenues and expenses on Fresenius Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Fresenius Medical Care. Please read more on our technical analysis and fundamental analysis pages.
KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. FRESEN MED is traded on Frankfurt Stock Exchange in Germany.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Fresenius Stock
When determining whether Fresenius Medical Care is a strong investment it is important to analyze Fresenius Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fresenius Medical's future performance. For an informed investment choice regarding Fresenius Stock, refer to the following important reports:Check out the analysis of Fresenius Medical Correlation against competitors. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.